AIKON Health
Developer of a non-invasive wearable monitoring solution for heart failure management. The company focuses on continuous at-home physiological monitoring, algorithm-driven digital biomarkers, and integration with clinical workflows to support early detection of deterioration and optimized medication titration for post-discharge heart failure patients.
Industries
Nr. of Employees
small (1-50)
Products
Wearable heart failure monitoring device (non-invasive)
A non-invasive, modular wearable sensor system intended for continuous at-home monitoring of heart failure–relevant physiological parameters (thoracic impedance, cardiac hemodynamics, 1-lead ECG, heart rate, respiratory metrics, posture).
Heart Failure Monitoring Device
A cutting-edge wearable device integrated with digital health solutions designed for continuous monitoring of heart failure specific parameters, empowering cardiologists and nurses in precise medication titration and effective management of HF patients.
AIKON Health Heart Failure Monitoring Solution
A proprietary device-enabled wearable solution designed to assist cardiologists and cardiology nurses in the effective post-discharge management of heart failure patients by continuously tracking key vital sign parameters and digital biomarkers.
AIKON Live
An innovative wearable solution providing continuous longitudinal data of patients post-discharge from the hospital, improving measurement adherence and empowering healthcare professionals.
Wearable heart failure monitoring device (non-invasive)
A non-invasive, modular wearable sensor system intended for continuous at-home monitoring of heart failure–relevant physiological parameters (thoracic impedance, cardiac hemodynamics, 1-lead ECG, heart rate, respiratory metrics, posture).
Heart Failure Monitoring Device
A cutting-edge wearable device integrated with digital health solutions designed for continuous monitoring of heart failure specific parameters, empowering cardiologists and nurses in precise medication titration and effective management of HF patients.
AIKON Health Heart Failure Monitoring Solution
A proprietary device-enabled wearable solution designed to assist cardiologists and cardiology nurses in the effective post-discharge management of heart failure patients by continuously tracking key vital sign parameters and digital biomarkers.
AIKON Live
An innovative wearable solution providing continuous longitudinal data of patients post-discharge from the hospital, improving measurement adherence and empowering healthcare professionals.
Services
Design and execution of analytical validation in healthy volunteers and clinical studies in heart failure patients to validate device performance and algorithms.
Integration of device data into hospital workflows and RPM solutions to support medication titration and remote patient management.
Design and execution of analytical validation in healthy volunteers and clinical studies in heart failure patients to validate device performance and algorithms.
Integration of device data into hospital workflows and RPM solutions to support medication titration and remote patient management.
Expertise Areas
- Remote patient monitoring
- Digital biomarker development and validation
- Wearable sensor development
- Clinical validation studies
Key Technologies
- Wearable biosensors
- Thoracic impedance monitoring
- Single-lead ECG
- Respiratory monitoring (rate, depth, variability)
News & Updates
Project overview describing development of a non-invasive wearable solution for continuous remote monitoring of heart failure and objectives including prototype development, algorithm refinement and clinical validation.
Announcement of a €1.2M seed funding round to advance remote heart failure monitoring.
Recognition for excellence via a Best Pre-Seed Pitch award at an investor summit.
Participation and funding under the OPZuid 2021–2027 programme to accelerate product development, testing and clinical validation in collaboration with research partners.
Project overview describing development of a non-invasive wearable solution for continuous remote monitoring of heart failure and objectives including prototype development, algorithm refinement and clinical validation.
Announcement of a €1.2M seed funding round to advance remote heart failure monitoring.
Recognition for excellence via a Best Pre-Seed Pitch award at an investor summit.
Participation and funding under the OPZuid 2021–2027 programme to accelerate product development, testing and clinical validation in collaboration with research partners.